Iqtadar S, Hashmat M, Chaudhry MNA, Mumtaz SU, Abaidullah S, Pascual-Figal DA, Khan A. Unnecessary Use of Corticosteroids for managing early mild symptoms of COVID-19 may lead to Rhino-ortibal-cerebral mucormycosis in Patients with Diabetes - a case series from Lahore, Pakistan. Ther Adv Infect Dis. 2022 May 6;9:20499361221097417. doi: 10.1177/20499361221097417. eCollection 2022 Jan-Dec. PubMed PMID: 35547833; PubMed Central PMCID: PMC9083038.
AÑO: 2022
|
Palau P, Amiguet M, Dominguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gomez Doblas JJ, de la Espriella R, Minana G, Mezcua AR, Santas E, Bodi V, Sanchis J, Pascual-Figal D, Gorriz JL, Bayes-Genis A, Nunez J; DAPA-VO2 Investigators (see Appendix). Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. PubMed PMID: 35604416.
AÑO: 2022; IF: 18.2
|
Pascual-Figal DA, Gonzalez-Juanatey JR. Environmental factors like air pollution: not to be forgotten in the 2021 ESC guidelines on heart failure. Response. Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):539. doi: 10.1016/j.rec.2022.02.009. Epub 2022 May 3. No abstract available. English, Spanish. PubMed PMID: 35523667.
AÑO: 2022; IF: 5.9
|
SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):364-369. doi: 10.1016/j.rec.2021.10.023. Epub 2022 Feb 11. No abstract available. English, Spanish. PubMed PMID: 35165071.
AÑO: 2022; IF: 5.9
|
Iqtadar S, Khan A, Mumtaz SU, Pascual-Figal DA, Livingstone S, Abaidullah S. Tocilizumab therapy for severely-ill COVID-19 pneumonia patients: a single-centre retrospective study. J Physiol Pharmacol. 2022 Aug;73(4). doi: 10.26402/jpp.2022.4.08. Epub 2023 Jan 20. PubMed PMID: 36696245.
AÑO: 2022; IF: 2.2
|